pSivida Corp. Announces Third Quarter Fiscal Year 2016 Financial Results Release Date and Conference Call Information
Apr 27, 2016
|
pSivida to Present at the Sidoti Spring 2016 Emerging Growth Convention
Mar 24, 2016
|
Additional Favorable Six-Month Safety Results for pSivida's Medidur™ for Posterior Uveitis
Mar 15, 2016
|
pSivida Corp. Provides Company Update and Reports Second Quarter FY 2016 Results
Feb 08, 2016
|
pSivida Corp Announces Second Quarter Fiscal Year 2016 Financial Results Release Date and Conference Call Information
Feb 01, 2016
|
pSivida CEO to Present at 18th Annual Bio CEO & Investor Conference February 9
Jan 28, 2016
|
pSivida Closes $17.8 Million Offering
Jan 13, 2016
|
pSivida Announces Pricing of $16 Million Public Offering of Common Stock
Jan 07, 2016
|
pSivida Announces Proposed Public Offering of Common Stock
Jan 06, 2016
|
pSivida Plans Medidur™ EU Marketing Approval Application Based on Single Phase 3 Clinical Trial
Dec 28, 2015
|
pSivida's Medidur™ Meets Primary Efficacy Endpoint in Phase 3 Trial: High Statistical Significance in Prevention of Recurrence of Posterior Uveitis (p Less Than 0.00000001)
Dec 22, 2015
|
pSivida Corp. Provides Company Update and Reports First Quarter FY 2016 Results
Nov 05, 2015
|
pSivida Corp Announces First Quarter FY 2016 Financial Results Release Date and Conference Call Information
Oct 30, 2015
|
pSivida Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs
Sep 28, 2015
|
pSivida CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015
Sep 14, 2015
|
pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2015 Results
Sep 09, 2015
|
pSivida CEO Invited to Speak at Surfaces in BioMaterials Foundation's BioInterface 2015 Annual Symposium
Sep 03, 2015
|
pSivida Corp Announces Fourth Quarter and Fiscal Year 2015 Financial Results Release Date and Conference Call Information
Sep 02, 2015
|
pSivida CEO to Speak at Controlled Release Society Annual Meeting Workshop in Edinburgh, Scotland, This Weekend
Jul 21, 2015
|
pSivida Announces Positive Top Line Results From Investigator-Sponsored Phase II Study of Medidur™ for Uveitis
Jul 13, 2015
|